MedCity News October 27, 2024
Dr. Anjali Malik

We should use AI to develop recommendations for breast cancer screening protocols based on quantified risk, factoring in family history, ethnicity, genetics, and density, et al. – and then support the use of powerful new imaging AI technologies for those cases that demand a deeper look.

Once again, the ongoing debate about the age women should begin annual breast screening is waging, as breast imaging radiologists, medical associations, and advocacy groups comment on the 2024 U.S. Preventive Services Task Force (USPSTF) recommendations for breast cancer screening. Their latest guidelines recommend that women should begin breast screening at age 40, a significant change from the 2015 USPSTF recommendations of starting at age 50.

In an editorial published in the Annals...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Technology
Related Articles:
The case for human-centered AI
European Commission Approves Nvidia’s Proposed Acquisition of Run:ai
How Health Systems Can Collaborate on AI Tools
The Future Talent Equation: How To Identify And Retain Talent In The Age Of AI
A Roadmap For AI In Education: Turning Disruption Into Opportunity

Share This Article